Vadakke Puthiyottil, S., Edayattil, A. and N K, S. 2026. Pathologic Response to Neoadjuvant Subcutaneous Fixed-Dose Pertuzumab–Trastuzumab (Phesgo®) and Chemotherapy in HER2-Positive Locally Advanced Breast Cancer: A Case Series and Literature Review. Asian Pacific Journal of Cancer Care. 11, 3 (May 2026), 481-488. DOI:https://doi.org/10.31557/apjcc.2026.11.3.481-488.